Risk Factors for Recurrent Urinary Tract Infection in Children

Status Completed

Clinical Trial Summary

The purpose of this study is to determine clinical and urodynamic risk factors for recurrent urinary tract infection in 5-18 years old children.

Clinical Trial Description

It is known, that in the group of young children the most common reason of recurrent UTI is anatomic abnormalities, such as vesicoureteral reflux, hydronephrosis. However, not all recurrent UTI can be explained by anatomic abnormalities. The vast majority of school age children with recurrent UTI have anatomically normal urinary tract. Recent studies discuss about the role of behavioral and functional abnormalities (inadequate fluid intake, stool retention, infrequent voiding, etc.) that can predispose recurrent urinary tract infections. Influence of some these abnormalities for recurrent UTI is controversial. Family history, behavioral and functional abnormalities which predispose to urinary tract infections in children with normal urinary tract are neglected in most protocols of urinary tract infection.

Children in this study receive a careful evaluation including complete history, voiding-drinking diary, bowel questionnaire, physical investigation, sonography, voiding cystourethrogram.

Follow up time - 1 year. Urinalysis once a month and during each episode of fever. ;

Study Design

Observational Model: Case Control, Time Perspective: Longitudinal

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00528476
Study type	Observational
Source	Kaunas University of Medicine
Contact
Status	Completed
Phase	N/A
Start date	November 2004
Completion date	January 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03235947` - Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients	Phase 4
Withdrawn	`NCT01881165` - Cranberry on Urinary Tract Infections	Phase 4
Terminated	`NCT02198833` - Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection	N/A
Completed	`NCT02357758` - Effects of Antibiotic Prophylaxis on Recurrent UTI in Children	Phase 4
Completed	`NCT01687114` - Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products	N/A
Completed	`NCT01391793` - Corticosteroids for Children With Febrile Urinary Tract Infections	Phase 3
Completed	`NCT01219595` - Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women	N/A
Completed	`NCT00365430` - SAFE or SORRY? Patient Safety Study of the Prevention of Adverse Patient Outcomes	N/A
Recruiting	`NCT04502095` - Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy	Phase 4
Completed	`NCT00976963` - Single Dose Monurol for Treatment of Acute Cystitis	N/A
Recruiting	`NCT02568800` - Prolonged Infusion Cefepime and Nosocomial Infections	Phase 3
Completed	`NCT02785445` - Healthy.io Method Comparison & User Performance Study	N/A
Completed	`NCT02216253` - L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection.	N/A
Completed	`NCT01478620` - Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)	Phase 3
Completed	`NCT01054690` - Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI)	N/A
Completed	`NCT00371631` - Colonizing Neurogenic Bladders With Benign Flora	Phase 1
Terminated	`NCT03697993` - Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)	Phase 4
Terminated	`NCT01803919` - Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients	N/A
Enrolling by invitation	`NCT01231737` - Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin)	Phase 2
Completed	`NCT01763008` - A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections	Phase 4